TOX is a critical regulator of tumour-specific T cell differentiation

Andrew Scott(Cornell University), Friederike Dündar(Cornell University), Paul Zumbo(Cornell University), Smita S. Chandran(Memorial Sloan Kettering Cancer Center), Christopher A. Klebanoff(Memorial Sloan Kettering Cancer Center), Mojdeh Shakiba(Weill Cornell Medicine), Prerak Trivedi(Memorial Sloan Kettering Cancer Center), Laura Menocal(Memorial Sloan Kettering Cancer Center), Heather Appleby(Memorial Sloan Kettering Cancer Center), Steven Camara(Memorial Sloan Kettering Cancer Center), Dmitriy Zamarin(Parker Institute for Cancer Immunotherapy), Tyler Walther(Memorial Sloan Kettering Cancer Center), Alexandra Snyder(Memorial Sloan Kettering Cancer Center), Matthew R. Femia(Parker Institute for Cancer Immunotherapy), Elizabeth Comen(Cornell University), Hannah Y. Wen(Memorial Sloan Kettering Cancer Center), Matthew D. Hellmann(Cornell University), Niroshana Anandasabapathy(Cornell University), Yong Liu(Cornell University), Nasser K. Altorki(Presbyterian Hospital), Peter Lauer(Aduro BioTech (United States)), Olivier Levy(Memorial Sloan Kettering Cancer Center), Michael S. Glickman(Memorial Sloan Kettering Cancer Center), Jonathan Kaye(Cedars-Sinai Medical Center), Doron Betel(Weill Cornell Medicine), Mary Philip(Vanderbilt University Medical Center), Andrea Schietinger(Parker Institute for Cancer Immunotherapy)
Nature
June 17, 2019
10.1038/s41586-019-1324-y
Cited by 1,089Open Access
Full Text

Abstract

Related Papers

No related papers found

Powered by citation graph analysis